US2017275257A1PendingUtilityA1

2-thiopyrimidinones

54
Assignee: PFIZERPriority: May 5, 2015Filed: Jun 9, 2017Published: Sep 28, 2017
Est. expiryMay 5, 2035(~8.8 yrs left)· nominal 20-yr term from priority
Inventors:Roger B. Ruggeri
C07D 239/56A61P 9/00A61K 31/513A61P 9/04A61P 9/10A61P 43/00A61K 45/06A61P 9/12A61K 2300/00
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Myeloperoxidase inhibitor, pharmaceutical compositions containing the inhibitor and the use of the inhibitor to treat, for example, cardiovascular conditions.

Claims

exact text as granted — not AI-modified
1 . A compound of the Formula I 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically acceptable salt thereof. 
     
     
         2 .- 7 . (canceled) 
     
     
         8 . A pharmaceutical combination composition comprising: a therapeutically effective amount of a composition comprising:
 a first compound, said first compound being a compound of  claim 1  or a pharmaceutically acceptable salt of said compound;   a second compound, said second compound being an angiotensin converting enzyme inhibitor, a HMG-CoA reductase inhibitor, neprilysin inhibitor, a non-steroidal anti-inflammatory agent, a Factor Xa inhibitor or warfarin; and   a pharmaceutical carrier, vehicle or diluent.

Join the waitlist — get patent alerts

Track US2017275257A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.